Peroxisome proliferator-activated receptor-g coactivator-1 (PGC-1) is highly expressed in brown adipose tissue (BAT) and plays an important role in adaptive thermogenesis. The aim of this study was to assess the acute effect of a b 3 -adrenergic agonist (Trecadrine) and leptin on the expression of PGC-1 and PPARg2 mRNA in BAT. Trecadrine produced a marked increase (4.5-fold) in PGC-1 mRNA compared to controls (PB0.001) without changes in PPARg2 mRNA, whereas leptin administration did not alter either PGC-1 or PPARg2 expression. These results show that selective stimulation of the b 3 -adrenoceptor rapidly upregulates the expression of PGC-1 in brown adipocytes without a concomitant increase in PPARg2. Moreover, our results show that PGC-1 and PPARg2 expression in BAT seems not to be acutely regulated by leptin.
Introduction
Adaptive thermogenesis is an important component of energy homeostasis and a physiological defence against obesity (Lowell and Spiegelman, 2000) . Brown adipose tissue (BAT) is of special interest in the study of adaptive thermogenesis because is the only tissue that works exclusively as a thermogenic organ due to its abundance of mitochondria, with ability to uncouple the oxidative phosphorylation through uncoupling protein (UCP) (Ricquier and Bouillaud, 2000) . In this context, it has been described that genetic ablation of BAT produces obesity in mice (Lowell et al., 1993) . Peroxisome proliferator-activated receptor-g (PPARg) are nuclear receptors strongly involved in adipogenesis and thermogenesis. Moreover, it has been described that these nuclear receptors are transcription factors controlling positively the expression of UCPs in BAT (Kelly et al., 1998) . The PPARg coactivator-1 (PGC-1) is a coactivator of PPARg, NRFs, TRb and RXRa highly expressed in BAT, but also in skeletal muscle, heart, kidney and brain. PGC-1 plays an important role in the expression of genes encoding proteins involved in adaptive thermogenesis through increases in the transcriptional activity of the above mentioned nuclear receptors (Puigserver et al., 1998; Wu et al., 1999) . Thermogenesis in BAT is primarily mediated by the sympathetic nervous system (SNS) through b-adrenergic receptors (b-AR) (Himms-Hagen, 1990) . b 3 -AR is the major b-AR subtype expressed in rodent BAT (D'Allaire et al., 1995) and its selective activation induces the expression of UCP1 with no clear effect on UCP2 and UCP3 expression (Puigserver et al., 1996; Savontaus et al., 1998; Yoshitomi et al., 1998; Gó mezAmbrosi et al., 1999) . It has been reported that b-AR activation by isoproterenol, a non-selective b agonist, increases the expression of PGC-1 mRNA in HIB 1B brown adipocytes differentiated in culture (Puigserver et al., 1998) . It has also been published that in vivo selective b 3 -AR stimulation induces the expression of PGC-1 in skeletal muscle in mice (Boss et al., 1999) . However, there is no evidence of in vivo regulation of PGC-1 mRNA expression in BAT by b-AR agonists or selective b 3 -AR agonists.
Leptin, the product of the ob gene, is an adipocytederived hormone which plays an important role in the energetic balance through regulation of food intake and energy expenditure (Ahima and Flier, 2000) . The mechanism of increased energy expenditure by leptin appears to involve long-term increased expression of UCP1 in BAT (Scarpace et al., 1997) . However, this increase does not take place acutely (Gó mez-Ambrosi et al., 1999) . The leptin-mediated stimulation of thermogenesis seems to be dependent on sympathetic innervation providing evidence of the existence of a loop involving SNS activity and leptin (Haynes et al., 1997) where PGC-1 could be involved.
In this study, we assessed the acute effect of intraperitoneal administration of either a b 3 -AR agonist or leptin on the expression of PGC-1 and PPARg2 mRNA in BAT of fasted rats and their possible relation with some indicators of thermogenesis and lipolysis.
Materials and methods

Animals and procedures
Five-month-old male Wistar rats weighing 420-430 g were housed at 2591°C with 12-h light cycle (8:00-20:00 h) and fed ad libitum. Animals were fasted overnight before drug administration. Rectal temperature of the rats was measured prior to i.p. injections of: saline, leptin (Peprotech, London, UK; 0.25 mg/kg) or the b 3 -AR agonist Trecadrine (Wasserman-Chiesi, Barcelona/Milan; 1 mg/kg, see reference (Barrionuevo et al., 1996) for chemical structure and pharmacological properties). The doses tested were used based on previous experiments showing physiological effects (Pelleymounter et al., 1995; Gó mez-Ambrosi et al., 1999) . One hour after administration, rectal temperature and oxygen consumption were measured. This time period has been shown to detect the maximal thermogenic effect after b 3 -AR agonist administration (Shih and Taberner, 1995) . Animals were killed by decapitation and trunk blood was collected. Interscapular BAT was excised, immediately frozen in liquid nitrogen and stored at −80°C until analysis. All experimental procedures were performed according to the 'Ethical principles and guidelines for scientific experiments on animals' of the Swiss Academy of Medical Sciences.
Blood analyses
Serum non-esterified fatty acid (NEFA) concentrations were measured by an enzymatic method (NEFA-C, ACS-ACOD Method, Wako Chemicals, Neuss, Germany). Glycerol levels were quantified by using an enzymatic colorimetric method (Randox Laboratories, Antrim, UK). Serum leptin concentrations were determined by means of a commercially available ELISA kit (Active™ Murine Leptin ELISA, Diagnostic System Laboratories, Webster, TX, USA).
Oxygen consumption and rectal temperature
Oxygen consumption was assessed by means of a Jacketed Oxygen Consumption Chamber (Harvard Apparatus, Edenbridge, UK). Rectal temperature was measured before and 1 h after drug administration by a rectal probe (Yellow Springs Instruments, Yellow Springs, OH, USA) connected to a Panlab thermometer pb 0331 (Panlab, Barcelona, Spain) as described previously (Gó mez-Ambrosi et al., 1999).
Semi-quantitati6e re6erse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated by the ULTRASPEC™-II RNA ISOLATION SYSTEM (Biotecx Laboratories, Houston, TX, USA) from 100 mg of BAT according to the manufacturer's instructions. The yield and quality of the RNA were assessed by measuring absorbance at 260 and 280 nm and by electrophoresis on 1.5% agarose gels. One microgram of RNA was used to synthesise first-strand cDNA after 30 min at 37°C treatment with 10 units of RNase free DNase I (Boehringer Mannheim Gmbh, Mannheim, Germany),. The RT reaction was carried out in a volume of 20 ml containing 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 , 10 mM dithiotreitol, 100 ng of random hexamers (Boehringer Mannheim), 1 mM each dNTP (Bioline, London, UK), 20 units of RNase inhibitor (Promega, Madison, WI, USA), 200 units of M-MLV RT (GIBCO BRL, Life Technologies, Gaithersburg, MD, USA) and incubated at 37°C for 60 min. The enzyme was inactivated by heating at 95°C for 5 min. Four microlitres from the RT reaction were amplified in a 50 ml reaction mixture containing 40 ng of each primer, 16 mM (NH 4 ) 2 SO 4 , 67 mM Tris -HCl (pH 8.8), 2 mM MgCl 2 , 0.1% Tween-20, 0.2 mM each dNTP and 1 unit of BIOTAQ™ polymerase (Bioline). Primers used to amplify PGC-1 cDNA (GenBank AB025784) were 5%-CCTTTCT-GAACTTGATGTGA-3% (sense, 146-165) and 5%-AT-GCTCTTTGCTTTATTGCT-3% (antisense, 603-622), PPARg2 (GenBank Y12882) 5%-TCTGATTATGGGT-GAAACTC-3%
(sense, 43-62) and 5%-TTTC-TACTCTTTTTGTGGATC-3% (antisense, 592-612) and b-actin (GenBank J00691) 5%-TCTACAAT-GAGCTGCGTGTG-3% (sense, 1599-1618) and 5%-GGTCAGGATCTTCATGAGGT-3%
(antisense, 2357-2376). Primers for PGC-1 and PPARg2 were designed using the Oligo ® 4.05 Primer Analysis Software (National Biosciences, Inc., Plymouth, MN, USA). cDNA was amplified for 34 (PGC-1), 43 (PPARg2) and 25 cycles (b-actin), using the following parameters: 94°C for 30 s, 52°C (PGC-1), 51°C (PPARg2) and 59°C (b-actin) for 30 s and 72°C for 30 s, with a final extension step at 72°C for 7 min. Although 43 cycles may seem to be a high number of cycles of amplification, it has been reported that during fasting, the otherwise elevated expression of PPARg2 in fat is dramatically reduced (Vidal-Puig et al., 1996) . Amplifications were linear under these conditions (Fig. 1) and were carried out in a GeneAmp ® PCR System 2400 (Perkin Elmer, Norwalk, CT, USA). Primers and conditions used for UCP1 mRNA quantification were the same as described previously (Gó mez-Ambrosi et al., 1999). All PCR reactions for each gene were performed at the same time and with the same batch of Taq polymerase in order to reduce variations in the efficiency of PCR. The amplified products were resolved in a 1.5% agarose gel with ethidium bromide. Levels of mRNA were expressed as the ratio of signal intensity for PGC-1 or PPARg2 relative to that for b-actin. PCR bands intensity were determined by densitometric analysis with the Gel Doc 1000 UV fluorescent gel documentation system and Molecular Analyst 1.4.1 software for quantitation of images (Bio-Rad, Hercules, CA, USA). The identity of PCR product amplifications was demonstrated after digestion with two restriction enzymes, yielding the predicted fragments in all the cases.
Statistical analysis
All results are expressed as mean9 SE. Data were analysed using a one-way ANOVA followed by Fisher's LSD posthoc test. Pearson's correlation coefficient (r) was computed to explore the correlations between two variables. The calculations were performed using the SPSS/Windows version 7.5.2S statistical package (SPSS, Chicago, IL, USA). A P value lower than 0.05 was considered statistically significant.
Results
Effects on blood biochemistry and indicators of thermogenesis
The b 3 -AR agonist Trecadrine produced a marked lipolytic effect after acute administration as evidenced by the increase observed in circulating concentrations of NEFA and glycerol. Leptin did not significantly alter either NEFA or glycerol levels. Trecadrine-induced lipolysis was accompanied by a rise in rectal temperature and whole body oxygen consumption, as well as by an elevation of UCP1 mRNA expression in BAT. Leptin produced a rise in rectal temperature, but did not affect oxygen consumption or UCP1 mRNA expression despite a 20-fold increase in serum leptin concentrations (Table  1) . Fig. 1 . Effects of the number of PCR cycles on the amplification of the cDNAs for b-actin (A), PGC-1 (B) and PPARg2 (C) synthesised after RNA obtained from interscapular BAT. Top, representative photographs of PCR products at different numbers of amplification cycles; bottom, band intensities were quantified by using Gel Doc 1000 UV fluorescent gel documentation system and Molecular Analyst 1.4.1 software (Bio-Rad) after ethidium bromide electrophoresis. mogenic cellular pathways of BAT. This activation was confirmed by the marked stimulation of lipolysis and thermogenesis elicited by Trecadrine in this short period of time. An in vivo induction of PGC-1 mRNA in skeletal muscle after b 3 -AR treatment has also been described (Boss et al., 1999) . However, this effect is likely to be indirect, given the fact that skeletal muscle does not seem to express physiologically significant amounts of b 3 -AR (Evans et al., 1996) . Boss et al. (1999) have suggested that PGC-1 expression in muscle could be induced by NEFA. In this sense, we have found an association between NEFA and PGC-1 mRNA expression in BAT, suggesting that NEFA may induce the expression of PGC-1 in several tissues in addition to muscle. It is known that b 3 -AR agonists produce hypertrophy of BAT (Ghorbani et al., 1997) and hypertrophy of adipose tissue is mediated by PPARg, at least in white adipose tissue (Kubota et al., 1999) . Also, Gros et al. (1999) have recently reported that expression of the b 3 -AR in CHO cells increases the expression of PPARg. Moreover, exposure of rats to cold, which in turn 3.
Effects on PGC-1 and PPARk2 mRNA expression in BAT
Trecadrine induced a 4.5-fold increase in PGC-1 mRNA expression in BAT (Fig. 2) 1 h after i.p. administration (PB0.001). However, PPARg2 mRNA levels were not significantly modified. Levels of PGC-1 and PPARg2 mRNA remained unaltered after acute leptin administration.
Pearson's correlation coefficient showed a statistically significant linear relationship between PGC-1 mRNA expression in BAT and UCP1 mRNA expression in BAT, circulating concentrations of NEFA and oxygen consumption (Fig. 3) .
Discussion
PGC-1 is a coactivator deeply involved in adaptive thermogenesis regulating the transcriptional activity of PPARg and other nuclear receptors (Puigserver et al., 1998) . In this sense, PGC-1 controls the expression of UCPs and turns on the biogenesis of mitochondria (Wu et al., 1999) .
It has been shown previously that non-selective b-AR agonists induce the expression of PGC-1 in cultured HIB 1B brown adipocytes after 6 h of stimulation and that b-AR may mediate the effect of cold exposure on the induction of PGC-1 (Puigserver et al., 1998) . Our results constitute the first evidence of the rapid (1 h) in vivo induction of PGC-1 mRNA expression in BAT by selective b 3 -AR stimulation. This finding seems to indicate that PGC-1 is one of the first molecules which are upregulated when it is necessary to activate the ther- found between expression of PGC-1 and indicators of thermogenesis such as UCP1 expression in BAT and whole body oxygen consumption.
The PGC-1 is reduced in fasting and elevated upon refeeding (Wu et al., 1999) . Therefore, we reasoned that leptin may be a candidate molecule to explain the observed changes. However, acute leptin treatment did not affect levels of PGC-1 in BAT. Leptin has been shown to increase lipolysis (Frü hbeck et al., 1998) and thermogenesis (Scarpace et al., 1997) . In this study, leptin did not stimulate lipolysis probably due to the low dose administered given the fact that higher doses are necessary to induce lipolysis in vivo (Frü hbeck et al., 1998) . Leptin-mediated long-term thermogenesis has been described to take place after several days by upregulation of UCP1 (Scarpace et al., 1997) . However, this effect is not observed acutely and other mechanisms such as upregulation of UCP3 in skeletal muscle have been proposed to explain the short-term rise in temperature induced by leptin (Gó mez- Ambrosi et al., 1999) . These observations and the lack of effect of leptin in the expression of PGC-1 seems to indicate that the thermogenic activation of BAT by leptin is SNSmediated and is only detected after long-term treatment.
There is no evidence of the effect of leptin on PPARg expression in BAT and the results concerning white adipose tissue are contradictory, since both upregulation (Qian et al., 1998) and downregulation have been found (Sanigorski et al., 2000) .
In conclusion, the present study shows that administration of a selective b 3 -AR agonist induces a rapid upregulation of PGC-1 mRNA expression in BAT of fasted rats in parallel to stimulating thermogenesis and lipolysis, without a concomitant increase in PPARg2 mRNA. Moreover, our results indicate that PGC-1 and PPARg2 expression in BAT seems not to be acutely regulated by leptin.
stimulates b 3 -AR, has been shown to activate the PPAR pathway in BAT (Guardiola-Díaz et al., 1999) . The fact that we have not detected any change in PPARg2 may be due to the acute experimental conditions. Our results, taken together with published data, indicate that PPARg2 receptors and their coactivation by PGC-1 are a key component of the early thermogenic response to b 3 -AR agonist in vivo in BAT, which is confirmed by the strong positive correlation
